EmboGuide with XperCT Dual provides the first workflow-based tool to guide detection and treatment of tumors and vessel feeders to multiple lesions. One study showed EmboGuide detects 39% more feeders than standard non-selective DSA¹
By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
For immediate technical support, please use the phone number below.
Philips Czech
Call: 800 193 358 (Green line)
Media Gallery
Features
A
Detects 39% more HCC feeders than DSA
EmboGuide with XperCT Dual provides the first workflow-based tool to guide detection and treatment of tumors and vessel feeders to multiple lesions. One study showed EmboGuide detects 39% more feeders than standard non-selective DSA.¹
Detects 39% more HCC feeders than DSA
EmboGuide with XperCT Dual provides the first workflow-based tool to guide detection and treatment of tumors and vessel feeders to multiple lesions. One study showed EmboGuide detects 39% more feeders than standard non-selective DSA.¹
Detects 39% more HCC feeders than DSA
EmboGuide with XperCT Dual provides the first workflow-based tool to guide detection and treatment of tumors and vessel feeders to multiple lesions. One study showed EmboGuide detects 39% more feeders than standard non-selective DSA.¹
EmboGuide with XperCT Dual provides the first workflow-based tool to guide detection and treatment of tumors and vessel feeders to multiple lesions. One study showed EmboGuide detects 39% more feeders than standard non-selective DSA.¹
MRI-like lesion detection in your lab
MRI-like lesion detection in your lab
XperCT Dual is the next evolution of XperCT, offering MRI-like lesion detection² in your oncology lab. The DualPhase acquisition* and DualView functions allow simultaneous visualization of two sequentially acquired 3D data sets.
MRI-like lesion detection in your lab
XperCT Dual is the next evolution of XperCT, offering MRI-like lesion detection² in your oncology lab. The DualPhase acquisition* and DualView functions allow simultaneous visualization of two sequentially acquired 3D data sets.
MRI-like lesion detection in your lab
XperCT Dual is the next evolution of XperCT, offering MRI-like lesion detection² in your oncology lab. The DualPhase acquisition* and DualView functions allow simultaneous visualization of two sequentially acquired 3D data sets.
XperCT Dual is the next evolution of XperCT, offering MRI-like lesion detection² in your oncology lab. The DualPhase acquisition* and DualView functions allow simultaneous visualization of two sequentially acquired 3D data sets.
Fast detection & volume measurement
Fast detection & volume measurement
A 3D lesion segmentation tool allows the user to isolate the regions in a 3D volume from MR, CT, or XperCT, using image-specific features.
Fast detection & volume measurement
A 3D lesion segmentation tool allows the user to isolate the regions in a 3D volume from MR, CT, or XperCT, using image-specific features.
Fast detection & volume measurement
A 3D lesion segmentation tool allows the user to isolate the regions in a 3D volume from MR, CT, or XperCT, using image-specific features.
A 3D lesion segmentation tool allows the user to isolate the regions in a 3D volume from MR, CT, or XperCT, using image-specific features.
Automatically detects feeder vessels
Automatically detects feeder vessels
Based on the segmented 3D volume, EmboGuide automatically analyzes the vasculature of lesions and provides suggestions about feeder vessels to the segmented lesions. The detected feeder vessels are annotated and added to the planning.
Automatically detects feeder vessels
Based on the segmented 3D volume, EmboGuide automatically analyzes the vasculature of lesions and provides suggestions about feeder vessels to the segmented lesions. The detected feeder vessels are annotated and added to the planning.
Automatically detects feeder vessels
Based on the segmented 3D volume, EmboGuide automatically analyzes the vasculature of lesions and provides suggestions about feeder vessels to the segmented lesions. The detected feeder vessels are annotated and added to the planning.
Based on the segmented 3D volume, EmboGuide automatically analyzes the vasculature of lesions and provides suggestions about feeder vessels to the segmented lesions. The detected feeder vessels are annotated and added to the planning.
Supports precise navigation to target
Supports precise navigation to target
EmboGuide offers unique 3D Live Image Guidance during the procedure. It creates a real-time overlay and registration of the 3D volume on the live X-ray images to support precise navigation of the device/catheter to the embolization target.
Supports precise navigation to target
EmboGuide offers unique 3D Live Image Guidance during the procedure. It creates a real-time overlay and registration of the 3D volume on the live X-ray images to support precise navigation of the device/catheter to the embolization target.
Supports precise navigation to target
EmboGuide offers unique 3D Live Image Guidance during the procedure. It creates a real-time overlay and registration of the 3D volume on the live X-ray images to support precise navigation of the device/catheter to the embolization target.
EmboGuide offers unique 3D Live Image Guidance during the procedure. It creates a real-time overlay and registration of the 3D volume on the live X-ray images to support precise navigation of the device/catheter to the embolization target.
EmboGuide with XperCT Dual provides the first workflow-based tool to guide detection and treatment of tumors and vessel feeders to multiple lesions. One study showed EmboGuide detects 39% more feeders than standard non-selective DSA.¹
Detects 39% more HCC feeders than DSA
EmboGuide with XperCT Dual provides the first workflow-based tool to guide detection and treatment of tumors and vessel feeders to multiple lesions. One study showed EmboGuide detects 39% more feeders than standard non-selective DSA.¹
Detects 39% more HCC feeders than DSA
EmboGuide with XperCT Dual provides the first workflow-based tool to guide detection and treatment of tumors and vessel feeders to multiple lesions. One study showed EmboGuide detects 39% more feeders than standard non-selective DSA.¹
EmboGuide with XperCT Dual provides the first workflow-based tool to guide detection and treatment of tumors and vessel feeders to multiple lesions. One study showed EmboGuide detects 39% more feeders than standard non-selective DSA.¹
MRI-like lesion detection in your lab
MRI-like lesion detection in your lab
XperCT Dual is the next evolution of XperCT, offering MRI-like lesion detection² in your oncology lab. The DualPhase acquisition* and DualView functions allow simultaneous visualization of two sequentially acquired 3D data sets.
MRI-like lesion detection in your lab
XperCT Dual is the next evolution of XperCT, offering MRI-like lesion detection² in your oncology lab. The DualPhase acquisition* and DualView functions allow simultaneous visualization of two sequentially acquired 3D data sets.
MRI-like lesion detection in your lab
XperCT Dual is the next evolution of XperCT, offering MRI-like lesion detection² in your oncology lab. The DualPhase acquisition* and DualView functions allow simultaneous visualization of two sequentially acquired 3D data sets.
XperCT Dual is the next evolution of XperCT, offering MRI-like lesion detection² in your oncology lab. The DualPhase acquisition* and DualView functions allow simultaneous visualization of two sequentially acquired 3D data sets.
Fast detection & volume measurement
Fast detection & volume measurement
A 3D lesion segmentation tool allows the user to isolate the regions in a 3D volume from MR, CT, or XperCT, using image-specific features.
Fast detection & volume measurement
A 3D lesion segmentation tool allows the user to isolate the regions in a 3D volume from MR, CT, or XperCT, using image-specific features.
Fast detection & volume measurement
A 3D lesion segmentation tool allows the user to isolate the regions in a 3D volume from MR, CT, or XperCT, using image-specific features.
A 3D lesion segmentation tool allows the user to isolate the regions in a 3D volume from MR, CT, or XperCT, using image-specific features.
Automatically detects feeder vessels
Automatically detects feeder vessels
Based on the segmented 3D volume, EmboGuide automatically analyzes the vasculature of lesions and provides suggestions about feeder vessels to the segmented lesions. The detected feeder vessels are annotated and added to the planning.
Automatically detects feeder vessels
Based on the segmented 3D volume, EmboGuide automatically analyzes the vasculature of lesions and provides suggestions about feeder vessels to the segmented lesions. The detected feeder vessels are annotated and added to the planning.
Automatically detects feeder vessels
Based on the segmented 3D volume, EmboGuide automatically analyzes the vasculature of lesions and provides suggestions about feeder vessels to the segmented lesions. The detected feeder vessels are annotated and added to the planning.
Based on the segmented 3D volume, EmboGuide automatically analyzes the vasculature of lesions and provides suggestions about feeder vessels to the segmented lesions. The detected feeder vessels are annotated and added to the planning.
Supports precise navigation to target
Supports precise navigation to target
EmboGuide offers unique 3D Live Image Guidance during the procedure. It creates a real-time overlay and registration of the 3D volume on the live X-ray images to support precise navigation of the device/catheter to the embolization target.
Supports precise navigation to target
EmboGuide offers unique 3D Live Image Guidance during the procedure. It creates a real-time overlay and registration of the 3D volume on the live X-ray images to support precise navigation of the device/catheter to the embolization target.
Supports precise navigation to target
EmboGuide offers unique 3D Live Image Guidance during the procedure. It creates a real-time overlay and registration of the 3D volume on the live X-ray images to support precise navigation of the device/catheter to the embolization target.
EmboGuide offers unique 3D Live Image Guidance during the procedure. It creates a real-time overlay and registration of the 3D volume on the live X-ray images to support precise navigation of the device/catheter to the embolization target.
*The DualPhase functionality is available with Allura systems release 8.2 or higher. It allows XperCT to perform two rotational scans with a user defined delay between them
1. Miyayama S, Yamashiro M, Nagai K, et al. Efficacy of automated tumor‐feeder detection software using cone‐beam computed tomography technology in transarterial embolization through extrahepatic collateral vessels for malignant hepatic tumors. Hepatology Research, 2016, 46(2): 166-173.
2. Loffroy R. et al., (2012). Cardiovasc Intervent Radiol. 2012 Feb;35(1):97-104. http://www.ncbi.nlm.nih.gov/pubmed/21328023
By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.
Vstupujete na českou webovou stránku Philips Healthcare
Please select the checkbox
Webová stránka je určena pouze osobám, které jsou odborníky (tj. osobám oprávněným zdravotnické prostředky předepisovat nebo vydávat), nebo zaměstnancům poskytovatele zdravotních služeb.
Jste osobou, která splňuje výše uvedená kritéria? Potvrzujete, že jste seznámeni s rizikem, že pokud budete pokračovat na tyto stránky, aniž jste osobou, která splňuje výše uvedená kritéria, hrozí, že informace tam obsažené budete nevhodně interpretovat a dojdete k mylným závěrům?
